Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

35.34USD
16 Apr 2014
Price Change (% chg)

$0.22 (+0.63%)
Prev Close
$35.12
Open
$35.54
Day's High
$35.72
Day's Low
$34.98
Volume
580,948
Avg. Vol
518,986
52-wk High
$40.87
52-wk Low
$27.51

Search Stocks
SABELLA LAUREN M
Trading Date Type Shares Traded Price Shares Held
4 Mar 2014 Buy 6,000 $0.00 18,403
4 Dec 2013 Sell 8,797 $31.81 12,403
1 Dec 2013 Sell 6,603 $33.52 21,200
21 Nov 2013 Sell 10,949 $33.72 27,803
5 Mar 2013 Buy 7,100 $0.00 38,752
3 Dec 2012 Sell 4,364 $24.58 31,652

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 228
Total Shares Held: 41,484,626
3 Mo. Net Change: 124,874
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Ron Cohen

57 President,Chief Executive Officer, Director

Michael Rogers

53 2013 Chief Financial Officer

Lauren Sabella

52 2010 Executive Vice President - Commercial Development

Andrew Blight

62 2004 Chief Scientific Officer

Jane Wasman

56 2012 President - International, General Counsel, Corporate Secretary

Enrique Carrazana

51 2011 Chief Medical Officer

David Lawrence

55 2013 Chief - Business Operations

Barry Greene

49 2007 Independent Director

Peder Jensen

58 2011 Independent Director

John Kelley

60 2008 Independent Director

Sandra Panem

66 1998 Independent Director

Lorin Randall

69 2006 Independent Director

Steven Rauscher

59 2005 Independent Director

Ian Smith

47 2007 Independent Director
Search Stocks